Molecular Characterization of the NCoA‐1–STAT 6 Interaction

Many protein–protein interactions involved in cell signalling, cell adhesion and regulation of transcription are mediated by short α‐helical recognition motifs with the sequence Leu‐Xaa‐Xaa‐Leu‐Leu (LXXLL, where Xaa is any amino acid). Originally observed in cofactors that interact with hormone‐activated nuclear receptors, LXXLL motifs are now known to occur in many transcription factors, including the STAT family, which transmit signals from activated cytokine receptors at the cell surface to target genes in the nucleus. STAT 6 becomes activated in response to IL‐4 and IL‐13, which regulate immune and anti‐inflammatory responses. Structural studies have revealed how an LXXLL motif located in 2.5 turns of an α‐helical peptide derived from STAT 6 provide contacts through the leucine side chains to the coactivator of transcription, NCoA‐1. However, since many protein–protein interactions are mediated by LXXLL motifs, it is important to understand how specificity is achieved in this and other signalling pathways. Here, we show that energetically important contacts between STAT 6 and NCoA‐1 are made in residues that flank the LXXLL motif, including the underlined residues in the sequence LLPPTEQDLTKLL. We also demonstrate how the affinity for NCoA‐1 of peptides derived from this region of STAT 6 can be significantly improved by optimising knobs‐into‐holes contacts on the surface of the protein. The results provide important new insights into the origins of binding specificity, and might be of practical value in the design of novel small‐molecule inhibitors of this important protein–protein interaction.

[1]  A. Hamilton,et al.  Helix mimetics as inhibitors of the interaction of the estrogen receptor with coactivator peptides. , 2007, Angewandte Chemie.

[2]  D. Hebenstreit,et al.  Signaling mechanisms, interaction partners, and target genes of STAT6. , 2006, Cytokine & growth factor reviews.

[3]  M. Kaplan,et al.  The role of constitutively active Stat6 in leukemia and lymphoma. , 2006, Critical reviews in oncology/hematology.

[4]  J. Trent,et al.  Potent Inhibitors of LXXLL‐Based Protein–Protein Interactions , 2005, Chembiochem : a European journal of chemical biology.

[5]  M. Ikura,et al.  The LxxLL motif: a multifunctional binding sequence in transcriptional regulation. , 2005, Trends in biochemical sciences.

[6]  Gerhard Wagner,et al.  A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein-protein interactions by fluorescence polarization. , 2004, Biochemistry.

[7]  Xueliang Fang,et al.  Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. , 2004, Analytical biochemistry.

[8]  R. Savkur,et al.  The coactivator LXXLL nuclear receptor recognition motif. , 2004, The journal of peptide research : official journal of the American Peptide Society.

[9]  C. Litterst,et al.  Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain. , 2004, Journal of molecular biology.

[10]  Yong Wang,et al.  Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor–coactivator interactions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R Kiplin Guy,et al.  Novel selective inhibitors of the interaction of individual nuclear hormone receptors with a mutually shared steroid receptor coactivator 2. , 2003, Journal of the American Chemical Society.

[12]  A Gene-Expression Inhibitor that Targets an α-Helix-Mediated Protein Interaction , 2003 .

[13]  C. Litterst,et al.  An LXXLL Motif in the Transactivation Domain of STAT6 Mediates Recruitment of NCoA-1/SRC-1* , 2002, The Journal of Biological Chemistry.

[14]  C. Litterst,et al.  Transcriptional Activation by STAT6 Requires the Direct Interaction with NCoA-1* , 2001, The Journal of Biological Chemistry.

[15]  R. Guy,et al.  An inhibitor of the interaction of thyroid hormone receptor beta and glucocorticoid interacting protein 1. , 2001, Journal of the American Chemical Society.

[16]  D. Fowlkes,et al.  Dissection of the LXXLL Nuclear Receptor-Coactivator Interaction Motif Using Combinatorial Peptide Libraries: Discovery of Peptide Antagonists of Estrogen Receptors α and β , 1999, Molecular and Cellular Biology.

[17]  D. Jameson,et al.  Quantification of protein-protein interactions using fluorescence polarization. , 1999, Methods.

[18]  P. Foster,et al.  STAT6: an intracellular target for the inhibition of allergic disease. , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[19]  C. Glass,et al.  Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. , 1998, Genes & development.

[20]  David M. Heery,et al.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors , 1997, Nature.